A clinical randomized double-blind placebo-controlled trial in the May 7, 2014 issue of the Archives of Medical Research found that oral magnesium supplements lowered C-Reactive Protein levels in prediabetic patients.
This is not the first time low blood levels of magnesium have been found to be correlated with elevated high-sensitivity C-reactive protein levels, a marker for inflammation.
Thursday, July 03, 2014
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment